P
MD icon

&Partners’s Pediatrix Medical MD Stock Holding History

&Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
+9,131
New +$208K ﹤0.01% 2297

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

&Partners's MD Position: Q2 2026 in Review

&Partners opened a new position in Pediatrix Medical (MD) in Q2 2026: 9,131 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings.

304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • &Partners held 9,131 shares of Pediatrix Medical worth $231K as of Q2 2026.
  • Pediatrix Medical was a new &Partners position in Q2 2026.
  • Pediatrix Medical made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2297 holding.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.